Credit Suisse’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.02M | Sell |
100,443
-27,329
| -21% | -$277K | ﹤0.01% | 2252 |
|
|
2023
Q4 | $1.29M | Sell |
127,772
-49,421
| -28% | -$497K | ﹤0.01% | 2167 |
|
|
2023
Q3 | $1.66M | Buy |
177,193
+32,425
| +22% | +$304K | ﹤0.01% | 1938 |
|
|
2023
Q2 | $3.55M | Sell |
144,768
-24,204
| -14% | -$594K | ﹤0.01% | 1545 |
|
|
2023
Q1 | $3.93M | Buy |
168,972
+43,034
| +34% | +$1M | ﹤0.01% | 1452 |
|
|
2022
Q4 | $3.19M | Buy |
125,938
+38,740
| +44% | +$981K | ﹤0.01% | 1593 |
|
|
2022
Q3 | $1.68M | Buy |
87,198
+25,262
| +41% | +$487K | ﹤0.01% | 1941 |
|
|
2022
Q2 | $1.58M | Buy |
61,936
+8,409
| +16% | +$214K | ﹤0.01% | 2061 |
|
|
2022
Q1 | $1.38M | Sell |
53,527
-3,630
| -6% | -$93.4K | ﹤0.01% | 2311 |
|
|
2021
Q4 | $2.39M | Buy |
57,157
+5,835
| +11% | +$244K | ﹤0.01% | 2039 |
|
|
2021
Q3 | $2.23M | Sell |
51,322
-6,851
| -12% | -$298K | ﹤0.01% | 2081 |
|
|
2021
Q2 | $2.75M | Buy |
58,173
+47,600
| +450% | +$2.25M | ﹤0.01% | 1960 |
|
|
2021
Q1 | $542K | Sell |
10,573
-51,263
| -83% | -$2.63M | ﹤0.01% | 2903 |
|
|
2020
Q4 | $1.66M | Buy |
+61,836
| New | +$1.66M | ﹤0.01% | 2244 |
|
|
2020
Q3 | – | Sell |
-5,804
| Closed | -$238K | – | 3313 |
|
|
2020
Q2 | $238K | Sell |
5,804
-2,506
| -30% | -$103K | ﹤0.01% | 3038 |
|
|
2020
Q1 | $285K | Buy |
+8,310
| New | +$285K | ﹤0.01% | 2855 |
|